{"id":50690,"date":"2023-09-22T14:14:34","date_gmt":"2023-09-22T18:14:34","guid":{"rendered":"https:\/\/hypertension.ca\/prevention-et-traitement\/traitement-de-lhypertension-associee-a-linsuffisance-cardiaque\/"},"modified":"2023-10-10T12:19:44","modified_gmt":"2023-10-10T16:19:44","slug":"traitement-de-lhypertension-associee-a-linsuffisance-cardiaque","status":"publish","type":"page","link":"https:\/\/hypertension.idlwebclients.com\/fr\/lignes-directrices\/prevention-et-traitement\/traitement-de-lhypertension-associee-a-linsuffisance-cardiaque\/","title":{"rendered":"Traitement de l\u2019hypertension associ\u00e9e \u00e0 l\u2019insuffisance cardiaque"},"content":{"rendered":"<div id=\"modal-ready\"><section class=\"l-section wpb_row us_custom_5c31ec89 event-banner-section height_medium width_full\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_top type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner us_custom_461a6918\"><div class=\"wpb_wrapper\"><div class=\"w-image img-w-100 align_center\"><div class=\"w-image-h\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1440\" height=\"252\" src=\"https:\/\/hypertension.idlwebclients.com\/wp-content\/uploads\/2023\/04\/HC-Guidelines-Credits-Page.jpg\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/hypertension.idlwebclients.com\/wp-content\/uploads\/2023\/04\/HC-Guidelines-Credits-Page.jpg 1440w, https:\/\/hypertension.idlwebclients.com\/wp-content\/uploads\/2023\/04\/HC-Guidelines-Credits-Page-300x53.jpg 300w, https:\/\/hypertension.idlwebclients.com\/wp-content\/uploads\/2023\/04\/HC-Guidelines-Credits-Page-1024x179.jpg 1024w, https:\/\/hypertension.idlwebclients.com\/wp-content\/uploads\/2023\/04\/HC-Guidelines-Credits-Page-200x35.jpg 200w, https:\/\/hypertension.idlwebclients.com\/wp-content\/uploads\/2023\/04\/HC-Guidelines-Credits-Page-600x105.jpg 600w, https:\/\/hypertension.idlwebclients.com\/wp-content\/uploads\/2023\/04\/HC-Guidelines-Credits-Page-1000x175.jpg 1000w, https:\/\/hypertension.idlwebclients.com\/wp-content\/uploads\/2023\/04\/HC-Guidelines-Credits-Page-500x88.jpg 500w, https:\/\/hypertension.idlwebclients.com\/wp-content\/uploads\/2023\/04\/HC-Guidelines-Credits-Page-700x123.jpg 700w\" sizes=\"(max-width: 1440px) 100vw, 1440px\" \/><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_top type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><h1 class=\"w-post-elm post_title us_custom_83a03b96 title-underline small-underline has_text_color entry-title color_link_inherit\">Traitement de l\u2019hypertension associ\u00e9e \u00e0 l\u2019insuffisance cardiaque<\/h1><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_887a049b height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_top type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"wpb_text_column sub-title\"><div class=\"wpb_wrapper\"><h2>Recommandations<\/h2>\n<\/div><\/div>[vc_empty_space height=\u00a0\u00bb20px\u00a0\u00bb]<div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><ul>\n<li>Chez la plupart des patients hypertendus atteints de coronaropathie, un inhibiteur ECA ou un ARA est recommand\u00e9 (grade A).<\/li>\n<li>Chez les patients hypertendus atteints de coronaropathie, mais sans insuffisance cardiaque systolique coexistante, l\u2019association d\u2019un inhibiteur ECA et d\u2019un ARA n\u2019est pas recommand\u00e9e (grade B).<\/li>\n<li>Pour les patients hypertendus \u00e0 risque \u00e9lev\u00e9, lorsqu\u2019un traitement d\u2019association est utilis\u00e9, les choix doivent \u00eatre personnalis\u00e9s. L\u2019association d\u2019un inhibiteur ECA et d\u2019un BCC dihydropyridine est pr\u00e9f\u00e9rable \u00e0 un inhibiteur ECA et \u00e0 un diur\u00e9tique de type thiazide\/thiazide chez certains patients (grade A).<\/li>\n<li>Pour les patients pr\u00e9sentant une angine de poitrine stable, mais sans insuffisance cardiaque ant\u00e9rieure, infarctus du myocarde ou pontage aortocoronarien, un beta-bloquant ou un BCC peut \u00eatre utilis\u00e9 comme traitement initial (grade B).<\/li>\n<li>La nif\u00e9dipine \u00e0 courte dur\u00e9e d\u2019action ne doit pas \u00eatre utilis\u00e9e (grade D).<\/li>\n<li>Lors de la diminution de la PAS \u00e0 des niveaux cibles chez les patients atteints d\u2019une MCV \u00e9tablie (surtout si une hypertension systolique isol\u00e9e est pr\u00e9sente), soyez prudent lorsque la PAD est de 60\u00a0mmHg en raison des pr\u00e9occupations que l\u2019isch\u00e9mie myocardique pourrait \u00eatre exacerb\u00e9e, en particulier chez les patients atteints d\u2019hypertrophie ventriculaire gauche (grade D).<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n<\/div>","protected":false},"excerpt":{"rendered":"Traitement de l\u2019hypertension associ\u00e9e \u00e0 l\u2019insuffisance cardiaque Recommandations [vc_empty_space height=\"20px\"] Chez la plupart des patients hypertendus atteints de coronaropathie, un inhibiteur ECA ou un ARA est recommand\u00e9 (grade A). Chez les patients hypertendus atteints de coronaropathie, mais sans insuffisance cardiaque systolique coexistante, l\u2019association d\u2019un inhibiteur ECA et d\u2019un ARA n\u2019est pas recommand\u00e9e (grade B). Pour...","protected":false},"author":4209,"featured_media":0,"parent":50665,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-50690","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/hypertension.idlwebclients.com\/fr\/wp-json\/wp\/v2\/pages\/50690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hypertension.idlwebclients.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hypertension.idlwebclients.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hypertension.idlwebclients.com\/fr\/wp-json\/wp\/v2\/users\/4209"}],"replies":[{"embeddable":true,"href":"https:\/\/hypertension.idlwebclients.com\/fr\/wp-json\/wp\/v2\/comments?post=50690"}],"version-history":[{"count":3,"href":"https:\/\/hypertension.idlwebclients.com\/fr\/wp-json\/wp\/v2\/pages\/50690\/revisions"}],"predecessor-version":[{"id":50820,"href":"https:\/\/hypertension.idlwebclients.com\/fr\/wp-json\/wp\/v2\/pages\/50690\/revisions\/50820"}],"up":[{"embeddable":true,"href":"https:\/\/hypertension.idlwebclients.com\/fr\/wp-json\/wp\/v2\/pages\/50665"}],"wp:attachment":[{"href":"https:\/\/hypertension.idlwebclients.com\/fr\/wp-json\/wp\/v2\/media?parent=50690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}